While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.
While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.
| December 1, 2012
Meet some of the people featured in the December 2012 issue of The Scientist.
Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.
Can emulating our early human ancestors make us healthier?
A protein called Coco rouses dormant breast cancer cells in the lung.
The Scientist’s 5th installment of its annual competition attracted submissions from across the life science spectrum. Here are the best and brightest products of the year.
Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.
Three-dimensional genome maps are leading to a deeper understanding of how the genome’s form influences its function.
A transplant of cells from the lining of the nose helps dogs with spinal injuries walk again.
Misfolded α-synuclein proteins promote the spread of Parkinson’s pathology in mouse brains.